The use of compounds in the treatment of skin disorders is described. In particular, the use of a compound of formula (I)or one of its pharmaceutically acceptable salts, pharmaceutically acceptable solvates or hydrates in the preparation of a medicament to treat inflammatory skin pathologies is described.